Concepts (54)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diagnosis, Computer-Assisted | 2 | 2017 | 95 | 1.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2017 | 155 | 0.960 |
Why?
|
| Heart Defects, Congenital | 4 | 2023 | 1815 | 0.840 |
Why?
|
| Fontan Procedure | 2 | 2023 | 182 | 0.750 |
Why?
|
| Scimitar Syndrome | 1 | 2022 | 52 | 0.750 |
Why?
|
| Mass Screening | 2 | 2017 | 782 | 0.710 |
Why?
|
| Pulmonary Veins | 1 | 2022 | 161 | 0.690 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 74 | 0.660 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 870 | 0.560 |
Why?
|
| Athletes | 1 | 2017 | 65 | 0.520 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 597 | 0.520 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2017 | 257 | 0.460 |
Why?
|
| Electroencephalography | 1 | 2016 | 864 | 0.370 |
Why?
|
| Electrocardiography | 1 | 2017 | 975 | 0.370 |
Why?
|
| Algorithms | 1 | 2017 | 1622 | 0.330 |
Why?
|
| Echocardiography | 3 | 2023 | 1052 | 0.290 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2023 | 11 | 0.220 |
Why?
|
| Palivizumab | 1 | 2023 | 47 | 0.210 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 38 | 0.210 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2878 | 0.200 |
Why?
|
| Pregnancy | 3 | 2023 | 7178 | 0.180 |
Why?
|
| Infant, Newborn | 3 | 2023 | 8191 | 0.170 |
Why?
|
| Guideline Adherence | 1 | 2023 | 382 | 0.170 |
Why?
|
| Ventricular Function | 1 | 2020 | 91 | 0.170 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 342 | 0.160 |
Why?
|
| Ventricular Function, Right | 1 | 2020 | 110 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2023 | 16334 | 0.160 |
Why?
|
| Infant | 3 | 2023 | 12475 | 0.150 |
Why?
|
| Female | 7 | 2023 | 66569 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2023 | 750 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2023 | 640 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2017 | 4804 | 0.140 |
Why?
|
| Child | 4 | 2023 | 24385 | 0.140 |
Why?
|
| Logistic Models | 1 | 2020 | 1812 | 0.120 |
Why?
|
| Heart Ventricles | 1 | 2020 | 762 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 607 | 0.120 |
Why?
|
| Male | 5 | 2023 | 61270 | 0.110 |
Why?
|
| United States | 2 | 2020 | 10899 | 0.110 |
Why?
|
| Humans | 8 | 2023 | 124727 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2017 | 1391 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2050 | 0.090 |
Why?
|
| Incidence | 1 | 2017 | 3142 | 0.080 |
Why?
|
| Adolescent | 2 | 2017 | 19288 | 0.080 |
Why?
|
| Risk Factors | 1 | 2020 | 10286 | 0.070 |
Why?
|
| Young Adult | 1 | 2017 | 9025 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2023 | 144 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 242 | 0.050 |
Why?
|
| Adult | 1 | 2020 | 29489 | 0.040 |
Why?
|
| Fetus | 1 | 2023 | 585 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 442 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2023 | 490 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2023 | 849 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2023 | 1269 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 1779 | 0.030 |
Why?
|